查詢結果分析
來源資料
相關文獻
- Improvement of Bone Metastases of a Case with Female Breast Cancer by Combined Zoledronic Acid Treatment
- Clodronate--治療乳癌的骨轉移
- Breast Cancer Metastasis Causing Bilateral Subtrochanteric Pathological Fractures: A Case Report
- A Solitary Sternal Metastasis Mimicking Physiological Uptake of Synchondrosis Sternalis in a Breast Cancer Patient: Case Report and Literature Review
- 照顧一位乳癌骨轉移病人不遵從服藥之護理經驗
- 針灸輔助治療乳癌骨轉移疼痛:一病例報告
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Cystic Hypersecretory Intraductal Carcinoma of the Breast--Case Report
- Timing of Shoulder Exercise after Modified Radical Mastectomy: A Prospective Study
頁籤選單縮合
題 名 | Improvement of Bone Metastases of a Case with Female Breast Cancer by Combined Zoledronic Acid Treatment=合併Zoledronic Acid治療改善一位女性乳癌患者之骨轉移 |
---|---|
作 者 | 黃彥閔; 吳宗翰; 王正旭; 黃仁聖; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 26:3 2010.06[民99.06] |
頁 次 | 頁125-132 |
分類號 | 416.226 |
關鍵詞 | 雙磷鹽酸; 乳癌; 骨轉移; Bisphosphate; Zoledronic acid; Breast cancer; Bone metastasis; |
語 文 | 英文(English) |
中文摘要 | 唑來磷酸 (Zoledronic acid,商品名:Zometa 卓骨祂 ) 為一雙磷酸鹽製劑,目前被廣 泛使用於骨質疏鬆以及高血鈣症的治療。增加的證據顯示 Zoledronic acid 可以減少乳癌 患者的蝕骨性骨轉移之骨骼併發症。本文報告一32 歲時罹停經前女性右側乳癌經改良式 根治性全乳房切除術患者,於手術後五年因嚴重背痛表現診斷骨轉移。在接受 doxorubicin 及 docetaxel 化學藥物與合併規則 Zoledronic acid 治療後背痛緩解並能恢復接近以往的 日常活動,同時骨掃描及磁振造影顯示骨轉移狀況改善。本文也回顧關於 Zoledronic acid 之文獻並做相關探討。 |
英文摘要 | Zoledronic acid is a bisphosphonate which is widely used in the treatment and prevention of osteoporosis and in the treatment of hypercalcemia. There is increasing evidence that zoledronic acid also prevents skeletal complications from metastatic osteolytic bone involvement in patients with breast cancer. We report a 32-year-old premenopausal woman with right breast cancer post modified radical mastectomy. Bone metastases were diagnosed after 5 years of operation when severe lower backache presented. The patient had received palliative chemotherapy with doxorubicin and docetaxel plus zoledronic acid 4 mg every 4 weeks. Her back pain improved, while bone scan and MRI also revealed improvement of bone metastases. She has nearly recovered activities of daily living. We also review the literature of zoledronic acid treatment for breast cancer. |
本系統中英文摘要資訊取自各篇刊載內容。